What has happened in the last 50 years in immunology

Journal of Paediatrics and Child Health

Volumn 51, Issue 2, 2015, Pages 135-139

  Wong, Melanie ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

advances; immunodeficiency; immunology

Indexed keywords

IMMUNOGLOBULIN; VITAMIN D;

AGAMMAGLOBULINEMIA; ALLERGIC DISEASE; ALLERGIC REACTION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COOMBS TEST; GENE THERAPY; HUMAN; HUMORAL IMMUNE DEFICIENCY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOLOGY; IMMUNOMODULATION; IMMUNOTHERAPY; INTESTINE FLORA; LONG TERM SURVIVAL; NEWBORN SCREENING; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; REVIEW; SEVERE COMBINED IMMUNODEFICIENCY; STEM CELL TRANSPLANTATION; SUBSTITUTION THERAPY; T LYMPHOCYTE SUBPOPULATION; GENETICS; HISTORY; IMMUNOLOGIC DEFICIENCY SYNDROMES; NEWBORN; PROCEDURES; TRENDS;

ALLERGY AND IMMUNOLOGY; GASTROINTESTINAL MICROBIOME; GENETIC THERAPY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT, NEWBORN; NEONATAL SCREENING;

EID: 84922618107     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/jpc.12834     Document Type: Review

References (34)

1. Gell PGH, Coombs RRA, eds. Clinical Aspects of Immunology. Oxford: Blackwell, 1963.
2. Cooper MD, Peterson RD, Good RA,. Delineation of the thymic and bursal lymphoid systems in the chicken. Nature 1965; 205: 143-146.
3. Bruton OC,. Agammaglobulinemia. Pediatrics 1952; 9: 722-728.
4. Vetrie D, Vorechovský I, Sideras P, et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 1993; 361: 226-233.
5. Berger M, Cupps TR, Fauci AS,. Immunoglobulin replacement therapy by slow subcutaneous infusion. Ann. Intern. Med. 1980; 93: 55-56.
6. Misbah S, Sturzenegger MH, Borte M, et al. Subcutaneous immunoglobulin: opportunities and outlook. Clin. Exp. Immunol. 2009; 158 (Suppl. 1): 51-59.
7. Imbach P, Barandun S, Baumgartner C, et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981; i: 1228-1231.
8. Boros P, Gondolesi G, Bromberg JS,. High dose intravenous immunoglobulin treatment: mechanisms of action. Liver Transpl. 2005; 11: 1469-1480.
9. Fudenberg HH, Good RA, Hitzig W, et al. Classification of the primary immune deficiencies: WHO recommendation. N. Engl. J. Med. 1970; 283: 656-657.
10. Notarangelo L, Casanova J-L, Conley ME, et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005. J. Allergy Clin. Immunol. 2006; 117: 883-896.
11. Al-Herz W, Bousfiha A, Casanova J-L, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency. Front. Immunol. 2014; 5: 162. Available from: http://primaryimmune.org/wp-content/uploads/2014/05/IUIS-Classification-April-2014.pdf [accessed 10 May 2014].
12. Noguchi M, Yi H, Rosenblatt HM, et al. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 1993; 73: 147-157.
13. Kovanen PE, Leonard WJ,. Cytokines and immunodeficiency diseases: critical roles of the γ-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways. Immunol. Rev. 2004; 202: 67-83.
14. Buckley RH,. The long quest for neonatal screening for severe combined immunodeficiency. J. Allergy Clin. Immunol. 2012; 129: 597-604.
15. Hacein-Bey-Abina S, Hauer J, Lim A, et al. Efficacy of gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 2010; 363: 355-364.
16. Williams DA,. Broadening the indications for hematopoietic stem cell genetic therapies. Cell Stem Cell. 2013; 13: 263-264.
17. Braun CJ, Boztug K, Paruzynski A, et al. Gene therapy for Wiskott-Aldrich syndrome-long-term efficacy and genotoxicity. Sci. Transl. Med. 2014; 6: 227ra33.
18. Kang EM, Choi U, Theobald N, et al. Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils. Blood 2010; 115: 783-791.
19. Hassan A, Booth C, Brightwell A, et al. Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency. Blood 2012; 120: 3615-3624.
20. Kwan A, Abraham RS, Currier R, et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA 2014; 312: 729-738.
21. Baker MW, Laessig RH, Katcher ML, et al. Implementing routine testing for severe combined immunodeficiency within Wisconsin's Newborn Screening Program. Public Health Rep. 2010; 125 (Suppl. 2): 88-95.
22. Yee A, De Ravin SS, Elliott E, Ziegler JB, Contributors to the Australian Paediatric Surveillance Unit. Severe combined immunodeficiency: a national surveillance study. Pediatr. Allergy Immunol. 2008; 19: 298-302.
23. Kohler G, Milstein C,. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495-497.
24. Meuer SC, Schlossman SF, Reinherz EL,. Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector cells recognize products of different major histocompatibility complex regions. PNAS 1982; 79: 4395-4399.
25. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL,. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 1986; 136: 2348-2357.
26. Strachan DP,. Hay fever, hygiene, and household size. BMJ 1989; 299: 1259-1260.
27. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M,. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995; 155: 1151-1164.
28. Wildin RS, Ramsdell F, Peake J, et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 2001; 27: 18-20.
29. Akdis M, Blaser K, Akdis CA,. T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. J. Allergy Clin. Immunol. 2005; 116: 961-969.
30. Milner JD, Brenchley JM, Laurence A, et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008; 452: 773-776.
31. Marwaha AK, Leung NJ, McMurchy AN, Levings MK,. TH17 cells in autoimmunity and immunodeficiency: protective or pathogenic? Front. Immunol. 2012; 3: 129.
32. Ma CS, Deenick EK, Batten M, Tangye SG,. The origins, function, and regulation of T follicular helper cells. J. Exp. Med. 2012; 209: 1241-1253.
33. Maslowski KM, Mackay CR,. Diet, gut microbiota and immune responses. Nat. Immunol. 2011; 12: 5-9.
34. Aranow C,. Vitamin D and the immune system. J. Investig. Med. 2011; 59: 881-886.